Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?

Takemori Yamawaki, Norihiro Suzuki

Research output: Contribution to journalArticlepeer-review

3 Citations (Scopus)

Fingerprint Dive into the research topics of 'Can immunoadsorption plasmapheresis be used as the first choice therapy for neuroimmunological disorders?'. Together they form a unique fingerprint.

Medicine & Life Sciences